Bone Biologics Corp (BBLG)
BBLG moved a median of -1.25% 30 minutes after news, and -1.67% by the close. How BBLG actually reacts to news — the realized, point-in-time move the market made, measured across 141 labeled events over the last three years with zero look-ahead.
BBLG’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 33% | 127 |
| 30-min | -1.25% | 39% | 140 |
| 60-min | -0.63% | 40% | 141 |
| to close | -1.67% | 41% | 141 |
| Middle 50% of BBLG reactions | -3.07% to +1.86% |
|---|---|
| Median reaction (30-min) | -1.25% |
| Measured reactions | 141 |
Half of all Bone Biologics Corp news events land between -3.07% and +1.86% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when BBLG moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to BBLG's baseline. Nothing else.
Recent BBLG events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K Bone Biologics Corp For: Sep 28 | SEC filing · Form 8-K | SEC EDGAR | -2.50% | +0.00% | |
| Form 8-K Bone Biologics Corp For: Sep 10 | SEC filing · Form 8-K | SEC EDGAR | -2.88% | +6.59% | |
| Bone Biologics Expands Trial Sites | Press release | GlobeNewswire | +2.42% | -1.94% | |
| Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference | Press release | GlobeNewswire | -4.33% | -3.81% | |
| Form DEF 14A Bone Biologics Corp For: Aug 28 | SEC filing · Form DEF | SEC EDGAR | -4.50% | -3.83% | |
| Form PRE 14A Bone Biologics Corp For: Aug 18 | SEC filing · Form PRE | SEC EDGAR | -1.28% | +0.31% | |
| Form 10-Q Bone Biologics Corp For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -2.15% | +2.33% | |
| Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1 | Press release | GlobeNewswire | -5.20% | -4.64% | |
| Form EFFECT Bone Biologics Corp | SEC filing · Form EFFECT | SEC EDGAR | +1.89% | -3.30% | |
| Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities | Press release | GlobeNewswire | +1.85% | +0.00% | |
| Form 8-K Bone Biologics Corp For: Jul 23 | SEC filing · Form 8-K | SEC EDGAR | +1.85% | +0.00% | |
| Form DEFA14A Bone Biologics Corp | SEC filing · Form DEFA14A | SEC EDGAR | -1.33% | -1.77% | |
| Form S-3 Bone Biologics Corp | SEC filing · Form S-3 | SEC EDGAR | -2.54% | -5.08% | |
| Form 8-K Bone Biologics Corp For: Jul 15 | SEC filing · Form 8-K | SEC EDGAR | +3.81% | -0.85% | |
| Form 8-K Bone Biologics Corp For: Jul 07 | SEC filing · Form 8-K | SEC EDGAR | — | +0.72% | |
| Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules | Press release | GlobeNewswire | -1.48% | -0.74% | |
| Form ARS Bone Biologics Corp For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | — | +1.43% | |
| Form DEF 14A Bone Biologics Corp For: Jul 02 | SEC filing · Form DEF | SEC EDGAR | — | +1.43% | |
| Form DEFA14A Bone Biologics Corp | SEC filing · Form DEFA14A | SEC EDGAR | — | +1.43% | |
| Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1 | Press release | GlobeNewswire | — | -1.56% | |
| Form 10-Q Bone Biologics Corp For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K Bone Biologics Corp For: Mar 13 | SEC filing · Form 8-K | SEC EDGAR | -1.20% | -2.40% | |
| Form 10-K Bone Biologics Corp For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | — | +5.71% | |
| Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook | Press release | GlobeNewswire | +0.00% | -1.90% | |
| Form 8-K Bone Biologics Corp For: Jan 08 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -1.90% | |
| Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months | Press release | GlobeNewswire | +5.79% | +2.63% | |
| Form 10-Q Bone Biologics Corp For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | — | +2.98% | |
| Form S-8 Bone Biologics Corp | SEC filing · Form S-8 | SEC EDGAR | -1.69% | +0.83% | |
| Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook | Press release | Business Wire | +0.00% | +2.89% | |
| Form 8-K Bone Biologics Corp For: Sep 04 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +2.89% | |
| Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference | Press release | Business Wire | -0.39% | -2.36% | |
| Form EFFECT Bone Biologics Corp | SEC filing · Form EFFECT | SEC EDGAR | -0.39% | -2.36% | |
| Form S-3/A Bone Biologics Corp | SEC filing · Form S-3 | SEC EDGAR | — | -0.46% | |
| Form 10-Q Bone Biologics Corp For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -5.91% | -7.17% | |
| Bone Biologics Announces Closing of $5.0 Million Public Offering | Press release | Business Wire | -3.33% | -5.88% | |
| Form 8-K Bone Biologics Corp For: Jun 27 | SEC filing · Form 8-K | SEC EDGAR | -3.33% | -5.88% | |
| Form EFFECT Bone Biologics Corp | SEC filing · Form EFFECT | SEC EDGAR | +1.41% | +3.60% | |
| Bone Biologics Announces Pricing of $5.0 Million Public Offering | Press release | Business Wire | -4.93% | -24.80% | |
| Bone Biologics Files Patent Application for Bone Regeneration Technology | Press release | Business Wire | -4.93% | -24.80% | |
| Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements | Press release | Business Wire | -4.93% | -24.80% | |
| Form 8-K Bone Biologics Corp For: Jun 25 | SEC filing · Form 8-K | SEC EDGAR | -4.93% | -24.80% | |
| Form S-1 Bone Biologics Corp | SEC filing · Form S-1 | SEC EDGAR | -3.40% | -20.94% | |
| Form S-3 Bone Biologics Corp | SEC filing · Form S-3 | SEC EDGAR | -3.40% | -20.94% | |
| Bone Biologics Announces 1-for-6 Reverse Stock Split | Press release | Business Wire | +3.02% | +7.91% | |
| Form 8-K Bone Biologics Corp For: Jun 05 | SEC filing · Form 8-K | SEC EDGAR | +3.02% | +7.91% | |
| Form 8-K Bone Biologics Corp For: May 30 | SEC filing · Form 8-K | SEC EDGAR | -12.15% | -15.32% | |
| Form 10-Q Bone Biologics Corp For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | — | +6.16% | |
| Form ARS Bone Biologics Corp For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -7.85% | -4.75% | |
| Form DEF 14A Bone Biologics Corp For: Dec 31 | SEC filing · Form DEF | SEC EDGAR | -7.85% | -4.75% | |
| Form 8-K Bone Biologics Corp For: Apr 07 | SEC filing · Form 8-K | SEC EDGAR | +1.45% | -2.44% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the BBLG section they belong to.
Where else BBLG is measured.
BBLG earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Bone Biologics Corp's median reaction calculated?
Every labeled BBLG news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 141 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 39% of BBLG's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does BBLG's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.